Article thumbnail

Transcriptomic Analysis of Host Immune and Cell Death Responses Associated with the Influenza A Virus PB1-F2 Protein

By Ronan Le Goffic, Olivier Leymarie, Christophe Chevalier, Emmanuelle Rebours, Bruno Da Costa, Jasmina Vidic, Delphyne Descamps, Jean-Michel Sallenave, Michel Rauch, Michel Samson and Bernard Delmas


Airway inflammation plays a major role in the pathogenesis of influenza viruses and can lead to a fatal outcome. One of the challenging objectives in the field of influenza research is the identification of the molecular bases associated to the immunopathological disorders developed during infection. While its precise function in the virus cycle is still unclear, the viral protein PB1-F2 is proposed to exert a deleterious activity within the infected host. Using an engineered recombinant virus unable to express PB1-F2 and its wild-type homolog, we analyzed and compared the pathogenicity and host response developed by the two viruses in a mouse model. We confirmed that the deletion of PB1-F2 renders the virus less virulent. The global transcriptomic analyses of the infected lungs revealed a potent impact of PB1-F2 on the response developed by the host. Thus, after two days post-infection, PB1-F2 invalidation severely decreased the number of genes activated by the host. PB1-F2 expression induced an increase in the number and level of expression of activated genes linked to cell death, inflammatory response and neutrophil chemotaxis. When generating interactive gene networks specific to PB1-F2, we identified IFN-γ as a central regulator of PB1-F2-regulated genes. The enhanced cell death of airway-recruited leukocytes was evidenced using an apoptosis assay, confirming the pro-apoptotic properties of PB1-F2. Using a NF-kB luciferase adenoviral vector, we were able to quantify in vivo the implication of NF-kB in the inflammation mediated by the influenza virus infection; we found that PB1-F2 expression intensifies the NF-kB activity. Finally, we quantified the neutrophil recruitment within the airways, and showed that this type of leukocyte is more abundant during the infection of the wild-type virus. Collectively, these data demonstrate that PB1-F2 strongly influences the early host response during IAV infection and provides new insights into the mechanisms by which PB1-F2 mediates virulence

Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2009). A complicated message: Identification of a novel PB1-related protein translated from influenza A virus segment 2 mRNA.
  2. (2001). A novel influenza A virus mitochondrial protein that induces cell death.
  3. (2007). A question of selfpreservation: immunopathology in influenza virus infection.
  4. (2007). A single mutation
  5. (2011). A single N66S mutation in the PB1-F2 protein of influenza A virus increases virulence by inhibiting the early interferon response in vivo.
  6. (2007). Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus.
  7. (1994). An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3.
  8. (2004). Design and performance testing of quantitative real time PCR assays for influenza A and B viral load measurement.
  9. (2006). Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virusinduced acute pneumonia.
  10. (2010). Differential localization and function of PB1-F2 derived from different strains of influenza A virus.
  11. (2007). Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia.
  12. (2006). Hijacking of the host-cell response and translational control during influenza virus infection.
  13. (2006). Influenza A virus PB1-F2 protein contributes to viral pathogenesis in mice.
  14. (2010). Influenza A virus protein PB1-F2 exacerbates IFN-beta expression of human respiratory epithelial cells.
  15. (2011). Influenza Virus Primes Mice for Pneumonia From Staphylococcus aureus.
  16. (2008). Inhibition of pulmonary antibacterial defense by interferon-gamma during recovery from influenza infection.
  17. (2009). Innate immunity and inflammation--two facets of the same anti-infectious reaction.
  18. (2009). Neutrophilmediated lung permeability and host defense proteins.
  19. (2009). Neutrophils ameliorate lung injury and the development of severe disease during influenza infection.
  20. (2010). PB1-F2 expression by the 2009 pandemic H1N1 influenza virus has minimal impact on virulence in animal models.
  21. (2010). PB1-F2 influenza A virus protein adopts a beta-sheet conformation and forms amyloid fibers in membrane environments.
  22. (2010). PB1-F2 proteins from H5N1 and 20 century pandemic influenza viruses cause immunopathology.
  23. (2004). PB1-F2, an influenza A virus-encoded proapoptotic mitochondrial protein, creates variably sized pores in planar lipid membranes.
  24. (2003). Preventing and treating influenza.
  25. Prince A (2009) Ca2+ signaling in airway epithelial cells facilitates leukocyte recruitment and transepithelial migration.
  26. (1999). Rescue of influenza A virus from recombinant DNA.
  27. (2010). The proapoptotic influenza A virus protein PB1-F2 forms a nonselective ion channel.
  28. (2008). The proapoptotic influenza A virus protein PB1-F2 regulates viral polymerase activity by interaction with the PB1 protein.
  29. (2010). Three amino acid changes in PB1-F2 of highly pathogenic H5N1 avian influenza virus affect pathogenicity in mallard ducks.
  30. (1997). Tissue injury in neutrophilic inflammation.